Languages
Pages
Legal
Explore all categories to find your favorite topic
Prepared by: Michel Cucherat, MD, PhD Faculté de médecine Laennec Lyon, France [email protected] Drug eluting stents A systematic review and meta-analysis of randomized…
1. Issue date: July 2008Review date: April 2009Drug-eluting stents for thetreatment of coronary arterydisease Part review of NICEtechnology appraisal guidance 71NICE technology…
1. Solaci 2012Update on the Current Status of Enduring DES Alexandre Abizaid, MD, PhD, FACC Instituto Dante Pazzanese de Cardiologia Sao Paulo, Brazil Columbia University…
Cardiovascular Outcomes in Patients with Drug Eluting Stents Undergoing Non-cardiac Surgery Boston Scientific Interventional Fellow, Royal Jubilee Hospital, Victoria, British…
DRAFT Contains Nonbinding Recommendations Draft â Not for Implementation 6255companion.doc 4/7/2008 Guidance for Industry Coronary Drug-Eluting Stents â Nonclinical and…
8/4/2019 Drug-Eluting Stents and Other Anti-Restenosis Devices 1/21842 Rev Esp Cardiol. 2005;58(7):842-62 104Restenosis remains as the main limitation of percuta-neous coronary…
Update on Interventional Cardiology – Bioabsorbable Stents Robert C. Welsh, MD, FRCPC Professor of Medicine Director, Adult Cardiac Catheterization and Interventional Cardiology…
1 Drug-Eluting Stents For SFA Interventions Ehrin J. Armstrong, MD MSc Director, Interventional Cardiology Director, Vascular Laboratory VA Eastern Colorado Healthcare System…
Drug-Eluting Balloon Angioplasty versus Bare Metal Stents for Femoropopliteal Disease in Real-World Experience Maria Doyle, M.Eng Hilary Coffey, M.D. Ravindra Gullipalli,…
The Detrimental Impact of Chronic Renal Insufficiency James Hermiller, MD, FACC, FSCAI The St Vincent Medical Group The St Vincent Heart Center of Indiana Indianapolis, IN…
Safety of Drug-Eluting Stents in Acute Coronary Syndromes Rotterdam, June 11th 2012 Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials…
c AZOTH Analytics November 2016 Global Coronary Stents Market Bare Metal Drug-Eluting Bioresorable: Analysis By Segment By Region By Country 2016-2021 • By Segment - Bare…
Clinical outcomes after primary PCI using contemporary drug eluting stents: evidence from a network meta-analysis Ply Chichareon MD Carlos Collet Bortone MD Rodrigo Modolo…
Hindawi Publishing Corporation ISRN Cardiology Volume 2013 Article ID 748736 8 pages http:dxdoiorg1011552013748736 Review Article Risk Factors for Coronary Drug-Eluting Stent…
Sponsored by Boston Scientific Corporation Volume 5, No. 6 Michael Jaff, MD Gunnar Tepe, MD Hans van Overhagen, MD Theodosios Bisdas, MD J.A. Mustapha, MD Fadi Saab, MD Dierk…
Biolimus A9 Drug-Eluting Stents: Technical Aspects and a Comprehensive Review of the EU, Asia-Pacific, and US Clinical Trial Program Eberhard Grube MD FACC, FSCAI HELIOS…
The recent introduction of drug-eluting stents in interventional cardiology has had a major impact on the treatment of coronary artery disease Online Appendix Online Table…
review article T h e n e w e ngl a nd j o u r na l o f m e dic i n e n engl j med 3683 nejm.org january 17, 2013254 Drug Therapy Drug-Eluting Coronary-Artery Stents Giulio…
Drug-Eluting Coronary-Artery Stentsreview article T h e n e w e ngl a nd j o u r na l o f m e dic i n e n engl j med 368;3 nejm.org january 17, 2013254 Drug Therapy Drug-Eluting
1. HEART INSTITUTE 2. Prediction of restenosis after PCI withcontemporary drug-eluting stents DR. ASHOK SETHFRCP (LOND), FRCP (EDIN), FRCP (IREL), FACC, FSCAI, FCSI, DSc.CHAIRMAN…